Document is current
Any future updates will be listed below
-
Authors
Theiler, Martin http://orcid.org/0000-0001-7160-3958
Knöpfel, Nicole http://orcid.org/0000-0002-6438-6550
von der Heydt, Susanne
Schwieger-Briel, Agnes http://orcid.org/0000-0001-7679-3981
Luchsinger, Isabelle http://orcid.org/0000-0001-7725-8171
Smith, Alexandra
Kernland-Lang, Kristin
Waelchli, Regula http://orcid.org/0000-0002-5396-7675
Neuhaus, Kathrin http://orcid.org/0000-0003-2438-1779
Kohler, Malcolm http://orcid.org/0000-0003-1800-8003
Gnannt, Ralph http://orcid.org/0000-0001-8120-6200
Schoch, Sarah F. http://orcid.org/0000-0002-3962-5804
Weibel, Lisa http://orcid.org/0000-0002-8696-8164
Kurth, Salome http://orcid.org/0000-0003-1432-4367
-
Funding
Funding for this research was provided by:
Universität Zürich (FK-18-047)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PCEFP1-181279)
Foundation for Research in Science and the Humanities (STWF-17-008)
Olga Mayenfisch Stiftung
- License Information
-
More Information
Article History
Received: 30 March 2021
Revised: 1 June 2021
Accepted: 3 June 2021
First Online: 18 June 2021
Declarations
:
: Ethical approval was obtained according to local standards (Cantonal ethics committee, BASEC 2018-01366, and 2016-00730)
: Written parental consent was obtained in all subjects before data collection.
: Written parental consent for publication was obtained in all subjects.
: Martin Theiler received honoraria from Pfizer, Janssen, Novartis, and Eli Lilly for investigator services, and from Sanofi-Aventis, Pfizer, and Novartis for participation on advisory boards and for consultancy. Lisa Weibel received honoraria from AbbVie, Pfizer, Eli Lilly, and Novartis for investigator services, and from Pierre Fabre, Sanofi-Aventis, Pfizer, Permamed, and Novartis for participation on advisory boards, as a speaker, and for consultancy. The other authors declared no conflicts of interest related to the content of this manuscript.
